The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

✍ Scribed by Jamil Y. Abuzetun; Fausto Loberiza; Julie Vose; Philip Bierman; R. Greg Bociek; Charles Enke; Martin Bast; Dennis Weisenburger; James O. Armitage; for the Nebraska Lymphoma Study Group

• Book ID: 108676109
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 264 KB
• Volume: 144
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2008.07500.x